Clinical Trial Update: Chlorhydrate of Ropivacaine and Breast Cancer Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating chlorhydrate of ropivacaine for breast cancer surgery has completed, per sponsor Institut Curie.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Ropivacaine hydrochloride (ropivacaine hydrochloride)

Snippet

Sponsor: Institut Curie | Conditions: Breast Neoplasms, Pain,Postoperative | Phase 4 | Status: COMPLETED